Figure - available from: Cancers
This content is subject to copyright.
Download
View publication
Elution profile of regorafenib.

Elution profile of regorafenib.

Source publication
Elution profile of sorafenib.
Elution profile of regorafenib.
Delayed phase angiography from hepatic artery demonstrating the tumor,...
H&E stain at 100× magnification showing coagulative necrosis of the...
+3 H&E stain at 25× magnification demonstrating a clump of DEEs with...
Drug-Eluting Embolic Loaded with Tyrosine Kinase Inhibitor Targeted Therapies for Transarterial Chemoembolization in a VX2 Model
Article
Full-text available
  • Jun 2023
Simple Summary Embolization shuts down vessels and cuts off the supply of blood to liver tumors. Using small beads, drugs can be delivered locally. Thus far, the drugs loaded onto the beads have not been tailored to liver tumors because the physical properties of efficacious drugs precluded it. Our patented formulation enables targeted therapies to...
Cite
Download full-text

Similar publications

Flow chart of research design.
Computed tomographic scans showing areas of skeletal muscle (red,...
The overall survival (OS) of patients in high and low SMI groups. (A)...
When the optimal cutoff value was selected as the cutoff value for...
Prognostic Effect of Sarcopenia in Hepatocellular Carcinoma Patients Targeted with Interventional Therapy Combined with Immunotherapy and Targeted Therapy
Article
Full-text available
  • Jan 2024
Objective To investigated the association between sarcopenia and the prognosis and adverse events of hepatocellular carcinoma (HCC) patients undergoing interventional therapy combined with immunotherapy and targeted therapy. Methods Between January 2019 and December 2022, patients with unresectable HCC who received interventional therapy combined...
View